EFCAB6 and cancer: Some downregulated genes (EHF and MMP14), mainly involved in proliferation and cancer development, were not restored upon EZH2 inhibitor treatment, and some that were upregulated in KO samples retained or even increased their high expression after treatment (EFCAB6 and CDKN2A) (Figure 5C).